Latest News and Press Releases

SAN DIEGO, Nov. 05, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold a conference call to discuss the Company’s financial results through September 30,...

SAN DIEGO, Oct. 15, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that Dr. J. Ribamar Costa from the Institute Dante Pazzanese of...

SAN DIEGO, Oct. 14, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) is pleased to announce that Dr. J. Ribamar Costa, from the Institute Dante Pazzanese of...

SAN DIEGO, Sept. 30, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) is pleased to announce that it has enrolled the first cohort of 110 patients in the FANTOM II clinical trial. Achievement...

SAN DIEGO, Aug. 20, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) is pleased to announce the appointment of Regina Groves as its Chief Executive Officer, effective September 21, 2015. Ms....

SAN DIEGO, Aug. 06, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold its quarterly briefing call to discuss operations and financial results through June...

SAN DIEGO, May 21, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") released initial clinical data on a subset of patients treated with the Fantom sirolimus-eluting...

SAN DIEGO, May 18, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that Dr. Alexandre Abizaid, Director of Invasive Cardiology at the Institute...

SAN DIEGO, May 14, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that the FANTOM II clinical trial is now enrolling patients with the...

SAN DIEGO, May 14, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold is 2015 Annual General Meeting of Stockholders (the "AGM") on Wednesday, May 27, 2015 at...